Streptococcus pneumoniae serotype 6B

Streptococcus pneumoniae serotype 6B is one variant within over one hundred known capsular types (“serotypes”) defined by differences in their surface polysaccharide capsule structure. The capsule serves as a major virulence factor by protecting bacteria from phagocytosis and interfering with complement-mediated clearance mechanisms in humans. Serogroup 6 includes several related types—most notably, types 6A and 6B—which differ only slightly in their oligosaccharide linkages but have distinct epidemiological profiles and immunogenicity. Serotypes like 6A/6B are important causes of invasive pneumococcal disease worldwide—including community-acquired pneumonia, meningitis, sepsis, otitis media—and have been included as antigens in conjugate vaccines due to their clinical significance.

Other names

S. pneumoniae serotype 6BPneumococcus type 6BSerogroup 6B pneumococcus

For antibiotics listed above—general mechanisms include inhibition of cell wall synthesis (beta-lactams), inhibition of protein synthesis (macrolides/tetracyclines), and inhibition of folate metabolism (trimethoprim/sulfamethoxazole). For vaccines—induction of protective antibodies against the capsular polysaccharide antigen specific to serotype 6B.